Possibilities of diphosphonates in the therapy of bone diseases
Bonjour, J.P.; Rizzoli, R.
Revue Medicale de la Suisse Romande 110(8): 691-694
1990
ISSN/ISBN: 0035-3655 PMID: 1699260 Document Number: 361350
Document emailed within 1 workday
Related Documents
Shvets, V.N.; Pankova, A.S.; Kabitskaya, O.E.; Vnukova, Z.E.; Morukov, B.V. 1986: Effect of diphosphonates on bone tissue of the rat during hypokinesia Kosmicheskaia Biologiia i Aviakosmicheskaia Meditsina 20(1): 45-49Morukov, B.V.; Zaĭchik, V.E.; Ivanov, V.M.; Orlov, O.I. 1987: Use of diphosphonates for correcting disorders of calcium metabolism and mineral composition of bone tissue in 60-day hypokinesia in rats Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1987(2): 75-77
Buffo, L.; Rossini, M.; Buoncristiano, A.; Girardello, S.; Zamberlan, N.; Diani, F.; Adami, S. 1996: Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate Minerva Ginecologica 48(6): 263-272
Diel, I.J. 1991: Current possibilities in the therapy and prevention of bone metastases in breast carcinoma? Zentralblatt für Gynakologie 113(19): 1023-1024
Purmová, J.; Opletal, L. 1995: Phytotherapeutic aspects of diseases of the cardiovascular system. 5. Saponins and possibilities of their use in prevention and therapy Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 44(5): 246-251
Kniazev, O.V.; Parfenov, A.I.; Ruchkina, I.N.; Konopliannikova, A.G.; Drozdov, V.N.; Sagynbaeva, V.É; Ivkina, T.I. 2013: New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases Terapevticheskii Arkhiv 85(2): 57-60
Purcell, H. 1994: Present and future possibilities in the use of calcium antagonists in the therapy of cardiovascular diseases with special emphasis on amlodipine Vnitrni Lekarstvi 40(8): 545
Mian, M.; Beghé, F.; Caprio, A.; Aloj, R.; Bertelli, A. 1991: Tolerability and safety of clodronate therapy in bone diseases International Journal of Clinical Pharmacology Research 11(2): 107-114
Maldague, B.; Malghem, J. 1982: Intracortical bone resorption: its diagnostic value in metabolic bone diseases associated with high bone-turnover Annales de Radiologie 25(5): 333-336
Wang, J.-d. 2009: Problem solving in endodontic diseases: IV. Diseases invading bone tissue that must be differentiated on X-ray from periapical diseases Zhonghua Kou Qiang Yi Xue Za Zhi 44(11): 697-701
Conte, N.; Breda, F.; Di Virgilio, R.; Legovini, P.; Roiter, I.; Foscolo, G.; Caenaro, G. 1988: Diphosphonates and primary hyperparathyroidism Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 3(4): 278-282
Clergeau-Guerithault, S. 1977: Diphosphonates and calcified tissues L' Information Dentaire 59(41): 21-31
Papapoulos, S.E.; Lockefeer, J.H. 1991: Diphosphonates in the treatment of osteoporosis Nederlands Tijdschrift Voor Geneeskunde 135(13): 553-556
Raviolo, P.; Galvagno, G.; Biarese, V.; Lovisetto, P. 1989: Diphosphonates. Current trends and therapeutic prospects La Clinica Terapeutica 129(1): 31-41
Korbelár, P. 1988: Possibilities of replacing bone tissue Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 55(3): 244-264
Yoshikawa, S. 1986: Etiology and pathology of metabolic bone diseases: Paget's disease of bone and osteosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2437-2442
Salzer-Kuntschik, M. 1971: Current nomenclature of primary bone neoplasms and tumor-like diseases of the bone (jaw-specific tumors excepted) Wiener Klinische Wochenschrift 83(31): 567-572
Jin, Y.; Yang, L.J. 1990: The relationship between bone morphogenetic protein and neoplastic bone diseases Clinical Orthopaedics and Related Research 259: 233-238
Hosoi, T. 2010: Cytokines in bone diseases. Wnt signal and excessive bone formation Clinical Calcium 20(10): 1526-1531
Liang, Y.; Wang, J.; Yu, S. 2000: Mechanisms of bone repairment in periapical diseases: studies on adjusting bone metabolism with calcium hydroxide in vitro Zhonghua Kou Qiang Yi Xue Za Zhi 35(2): 112-114